Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosis.

Rumpf JJ, Dietrich S, Stoppe M, Fricke C, Weise D, Then Bergh F, Classen J.

J Neurol. 2018 Aug 6. doi: 10.1007/s00415-018-8993-6. [Epub ahead of print]


Treatment choices and neuropsychological symptoms of a large cohort of early MS.

von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kümpfel T, Stangel M, Heesen C, Wildemann B, Paul F, Bayas A, Warnke C, Weber F, Linker RA, Ziemann U, Zettl UK, Zipp F, Wiendl H, Hemmer B, Gold R, Salmen A.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 1;5(3):e446. doi: 10.1212/NXI.0000000000000446. eCollection 2018 May.


Outcome of MS relapses in the era of disease-modifying therapy.

Stoppe M, Busch M, Krizek L, Then Bergh F.

BMC Neurol. 2017 Aug 7;17(1):151. doi: 10.1186/s12883-017-0927-x.


Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.

Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.

Psychoneuroendocrinology. 2017 Apr;78:39-47. doi: 10.1016/j.psyneuen.2017.01.004. Epub 2017 Jan 16.


Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis.

Bechmann L, Busse K, Stoppe M, Cotte S, Ettrich B, Then Bergh F.

J Neuroimmunol. 2014 Nov 15;276(1-2):159-65. doi: 10.1016/j.jneuroim.2014.07.004. Epub 2014 Jul 15.


Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis.

Stoppe M, Thomä E, Liebert UG, Major EO, Hoffmann KT, Claßen J, Then Bergh F.

J Neurol. 2014 May;261(5):1021-4. doi: 10.1007/s00415-014-7311-1. Epub 2014 Mar 18. No abstract available.


Supplemental Content

Loading ...
Support Center